PMID- 31830394 OWN - NLM STAT- MEDLINE DCOM- 20200528 LR - 20200528 IS - 1724-5990 (Electronic) IS - 0393-5590 (Linking) VI - 36 IP - 6 DP - 2019 Dec 9 TI - [Economic impact of kidney patients with sepsis in hospital setting]. LID - 2019-vol6 [pii] AB - Introduction: Over the last decades, sepsis has become a real medical emergency, with a high mortality rate and often requiring admission to an intensive care unit. An increasing number of CKD patients contracts sepsis due to several clinical risk factors (use of catheters, immunosuppressive therapy, comorbidity, etc.) and is treated in Nephrology wards, generating additional costs that are not covered by hospital Diagnosis Related Groups (DRG) reimbursement. The aim of the study is to evaluate the costs of sepsis in one Nephrology Unit and to detect the mortality rate of CKD patients with sepsis. Methods: We conducted a retrospective study on a cohort of CKD patients admitted into one Nephrology Unit in 2017. CKD inpatients were divided in two groups: patients with sepsis (SP) and without (control group). Socio-demographic, clinical and therapeutic data, as well as routine biochemistry, were collected through a "sepsis form". SP were identified thanks to hospital discharge records (HDR). The hospital-related costs of a SP were obtained by summing up: (1) the average cost of an inpatient day of care for the average length of stay in the Nephrology Unit; (2) the average cost of the antimicrobial therapy, as recorded on the clinical folder. Results: Among the 408 CKD inpatients, 61 were septic. The overall average cost of a SP was 23.087,57 euro; the average cost of the hospital stay and of the antimicrobial therapy was 19.364,98 euro and 3.722,60 euro respectively. The average length of stay in the Nephrology Unit was 16.7 days. The in-hospital mortality rate was 41.7%, with a 312% additional mortality rate. Conclusions: SP had an overall average cost three times higher than CKD inpatients without sepsis (9.290,79 euro). This additional cost was due to a longer hospital stay (8.7 days more on average) and a higher cost of antimicrobial therapy per case (euro 221,24). A national multi-centre study is needed to confirm our data and to promote an adjustment of reimbursement tariff for DRG-sepsis, which is now applicable only to an ICU setting. CI - Copyright by Societa Italiana di Nefrologia SIN, Rome, Italy. FAU - Battaglia, Yuri AU - Battaglia Y AD - UOC di Nefrologia e Dialisi, AOU "Sant'Anna", Ferrara, Italia. FAU - Guerzoni, Franco AU - Guerzoni F AD - Nucleo Aziendale Controlli, AOU "Sant'Anna", Ferrara, Italia. FAU - Gigante, Manuel AU - Gigante M AD - UOC di Nefrologia e Dialisi, AOU "Sant'Anna", Ferrara, Italia. FAU - Veronesi, Marco AU - Veronesi M AD - UOC di Nefrologia e Dialisi, AOU "Sant'Anna", Ferrara, Italia. FAU - Oppi, Chiara AU - Oppi C AD - Dipartimento di Economia e Management, Universita di Ferrara, Italia. FAU - Forini, Elena AU - Forini E AD - Ufficio Statistico, AOU "Sant'Anna", Ferrara, Italia. FAU - Ullo, Ines AU - Ullo I AD - UOC di Nefrologia e Dialisi, ASST Sette Laghi, Varese, Italia. FAU - Vagnoni, Emidia AU - Vagnoni E AD - Dipartimento di Economia e Management, Universita di Ferrara, Italia. FAU - Storari, Alda AU - Storari A AD - UOC di Nefrologia e Dialisi, AOU "Sant'Anna", Ferrara, Italia. LA - ita PT - Journal Article DEP - 20191209 PL - Italy TA - G Ital Nefrol JT - Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia JID - 9426434 SB - IM MH - Aged MH - Aged, 80 and over MH - Female MH - *Health Care Costs MH - Hospitalization/*economics MH - Humans MH - Male MH - Middle Aged MH - Renal Insufficiency, Chronic/complications/*economics/*therapy MH - Retrospective Studies MH - Sepsis/complications/*economics/*therapy OTO - NOTNLM OT - costs OT - hospital discharge register OT - kidney disease OT - sepsis EDAT- 2019/12/13 06:00 MHDA- 2020/05/29 06:00 CRDT- 2019/12/13 06:00 PHST- 2019/12/13 06:00 [entrez] PHST- 2019/12/13 06:00 [pubmed] PHST- 2020/05/29 06:00 [medline] AID - 36-06-2019-8 [pii] PST - epublish SO - G Ital Nefrol. 2019 Dec 9;36(6):2019-vol6.